vs

Side-by-side financial comparison of Precipio, Inc. (PRPO) and VALUE LINE INC (VALU). Click either name above to swap in a different company.

VALUE LINE INC is the larger business by last-quarter revenue ($8.3M vs $6.8M, roughly 1.2× Precipio, Inc.). VALUE LINE INC runs the higher net margin — 71.4% vs 7.7%, a 63.7% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -7.7%). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs -4.1%).

Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.

Value Line, Inc. is a publicly traded investment research and financial publishing firm based in New York City. Founded in 1931 by Arnold Bernhard, Value Line is best known for publishing The Value Line Investment Survey, a stock analysis newsletter that tracks approximately 1,700 publicly traded stocks.

PRPO vs VALU — Head-to-Head

Bigger by revenue
VALU
VALU
1.2× larger
VALU
$8.3M
$6.8M
PRPO
Growing faster (revenue YoY)
PRPO
PRPO
+36.1% gap
PRPO
28.4%
-7.7%
VALU
Higher net margin
VALU
VALU
63.7% more per $
VALU
71.4%
7.7%
PRPO
Faster 2-yr revenue CAGR
PRPO
PRPO
Annualised
PRPO
40.0%
-4.1%
VALU

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
PRPO
PRPO
VALU
VALU
Revenue
$6.8M
$8.3M
Net Profit
$526.0K
$5.9M
Gross Margin
45.9%
Operating Margin
7.9%
12.1%
Net Margin
7.7%
71.4%
Revenue YoY
28.4%
-7.7%
Net Profit YoY
244.1%
14.5%
EPS (diluted)
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRPO
PRPO
VALU
VALU
Q1 26
$8.3M
Q4 25
$6.8M
$8.6M
Q3 25
$6.9M
$8.6M
Q2 25
$5.6M
$8.4M
Q1 25
$4.9M
$9.0M
Q4 24
$5.3M
$8.8M
Q3 24
$5.3M
$8.9M
Q2 24
$4.5M
$9.0M
Net Profit
PRPO
PRPO
VALU
VALU
Q1 26
$5.9M
Q4 25
$526.0K
$5.7M
Q3 25
$-79.0K
$6.5M
Q2 25
$74.0K
$4.0M
Q1 25
$-884.0K
$5.2M
Q4 24
$-365.0K
$5.7M
Q3 24
$-626.0K
$5.9M
Q2 24
$-1.2M
$4.8M
Gross Margin
PRPO
PRPO
VALU
VALU
Q1 26
Q4 25
45.9%
Q3 25
43.6%
Q2 25
43.2%
Q1 25
43.6%
Q4 24
49.8%
Q3 24
43.1%
Q2 24
38.1%
Operating Margin
PRPO
PRPO
VALU
VALU
Q1 26
12.1%
Q4 25
7.9%
17.7%
Q3 25
-0.9%
17.4%
Q2 25
-14.6%
9.9%
Q1 25
-17.5%
17.4%
Q4 24
-6.3%
19.7%
Q3 24
-11.3%
20.8%
Q2 24
-26.8%
16.5%
Net Margin
PRPO
PRPO
VALU
VALU
Q1 26
71.4%
Q4 25
7.7%
66.4%
Q3 25
-1.1%
75.1%
Q2 25
1.3%
47.1%
Q1 25
-18.0%
57.6%
Q4 24
-6.9%
64.3%
Q3 24
-11.9%
66.3%
Q2 24
-27.1%
53.1%
EPS (diluted)
PRPO
PRPO
VALU
VALU
Q1 26
Q4 25
$0.36
Q3 25
$-0.05
Q2 25
$0.05
Q1 25
$-0.59
Q4 24
$-0.22
Q3 24
$-0.42
Q2 24
$-0.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRPO
PRPO
VALU
VALU
Cash + ST InvestmentsLiquidity on hand
$2.7M
$92.5M
Total DebtLower is stronger
$83.0K
Stockholders' EquityBook value
$14.6M
$107.8M
Total Assets
$21.3M
$151.0M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRPO
PRPO
VALU
VALU
Q1 26
$92.5M
Q4 25
$2.7M
$86.6M
Q3 25
$2.3M
$33.7M
Q2 25
$1.1M
$67.7M
Q1 25
$1.0M
$52.8M
Q4 24
$1.4M
$22.3M
Q3 24
$1.1M
$30.9M
Q2 24
$1.3M
$4.4M
Total Debt
PRPO
PRPO
VALU
VALU
Q1 26
Q4 25
$83.0K
Q3 25
Q2 25
Q1 25
Q4 24
$383.0K
Q3 24
Q2 24
Stockholders' Equity
PRPO
PRPO
VALU
VALU
Q1 26
$107.8M
Q4 25
$14.6M
$105.5M
Q3 25
$13.7M
$103.0M
Q2 25
$12.3M
$99.7M
Q1 25
$11.7M
$99.0M
Q4 24
$12.1M
$96.7M
Q3 24
$11.9M
$93.9M
Q2 24
$12.1M
$90.8M
Total Assets
PRPO
PRPO
VALU
VALU
Q1 26
$151.0M
Q4 25
$21.3M
$147.9M
Q3 25
$21.2M
$148.2M
Q2 25
$18.8M
$144.5M
Q1 25
$17.8M
$143.6M
Q4 24
$17.0M
$140.0M
Q3 24
$17.0M
$138.6M
Q2 24
$17.3M
$136.0M
Debt / Equity
PRPO
PRPO
VALU
VALU
Q1 26
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRPO
PRPO
VALU
VALU
Operating Cash FlowLast quarter
$366.0K
$5.3M
Free Cash FlowOCF − Capex
$291.0K
FCF MarginFCF / Revenue
4.3%
Capex IntensityCapex / Revenue
1.1%
0.0%
Cash ConversionOCF / Net Profit
0.70×
0.89×
TTM Free Cash FlowTrailing 4 quarters
$359.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRPO
PRPO
VALU
VALU
Q1 26
$5.3M
Q4 25
$366.0K
$3.0M
Q3 25
$10.0K
$5.6M
Q2 25
$353.0K
$20.2M
Q1 25
$-44.0K
$6.9M
Q4 24
$565.0K
$3.1M
Q3 24
$41.0K
$4.8M
Q2 24
$500.0K
$17.9M
Free Cash Flow
PRPO
PRPO
VALU
VALU
Q1 26
Q4 25
$291.0K
Q3 25
$-44.0K
Q2 25
$294.0K
$20.1M
Q1 25
$-182.0K
$6.8M
Q4 24
$3.0M
Q3 24
$-68.0K
$4.8M
Q2 24
$17.9M
FCF Margin
PRPO
PRPO
VALU
VALU
Q1 26
Q4 25
4.3%
Q3 25
-0.6%
Q2 25
5.2%
239.2%
Q1 25
-3.7%
75.3%
Q4 24
34.1%
Q3 24
-1.3%
53.7%
Q2 24
199.0%
Capex Intensity
PRPO
PRPO
VALU
VALU
Q1 26
0.0%
Q4 25
1.1%
0.0%
Q3 25
0.8%
0.0%
Q2 25
1.0%
2.1%
Q1 25
2.8%
1.2%
Q4 24
0.7%
Q3 24
2.1%
0.0%
Q2 24
0.2%
Cash Conversion
PRPO
PRPO
VALU
VALU
Q1 26
0.89×
Q4 25
0.70×
0.52×
Q3 25
0.86×
Q2 25
4.77×
5.12×
Q1 25
1.33×
Q4 24
0.54×
Q3 24
0.81×
Q2 24
3.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons